Impregnation of mesoporous silica with poor aqueous soluble molecule using pressurized carbon dioxide: is the solubility in the supercritical and subcritical phase a critical parameter?
[en] Recently, mesoporous silica (MS) has been used as a material able to maintain amorphous state of active compounds and therefore, enhance the oral bioavailability of BCSII drugs. Among impregnation methods of MS, techniques using supercritical carbon dioxide (sc-CO2) are promising tools. Solubility of compounds in sc-CO2 is reported as one of the most critical parameters, which usually limits its use in drug formulation. Indeed, most of compounds have poor solubility in sc-CO2. The aim of this work is to compare different MS and to study alternative processes using pressurized CO2 for insoluble molecule in sc-CO2. By using high pressure reactor, DSC, HPLC and in vitro dissolution tests, the crystallinity and dissolution profiles of MS with different pore size (6.6 nm, 25.0 nm and 2.5 nm) impregnated with fenofibrate (FF) under sc-CO2 were compared to select the most appropriate carrier. Then, the selected MS has been impregnated under supercritical, subcritical and atmospheric conditions. We have shown that the MS pore size of 6.6 nm provides the higher amorphous drug loading capacity as well as the faster and higher drug dissolution. In addition, FF-MS formulations produced with pressurized CO2 as fusion medium, both in subcritical and supercritical conditions; give similar crystallinity and dissolution results compared to those produced with supercritical fluids as solvent. Through this study, we show new possibilities of using CO2 for insoluble compounds in this fluid.
Research center :
Center for Education and Research on Macromolecules (CERM) Complex and Entangled Systems from Atoms to Materials (CESAM) Research Unit Laboratory of Pharmaceutical Technology and Biopharmacy
Koch, Nathan ; University of Liège (ULiège), Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, Belgium
Jennotte, Olivier ; University of Liège (ULiège), Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, Belgium
Grignard, Bruno ; University of Liège (ULiège), Complex and Entangled Systems from Atoms to Materials (CESAM) Research Unit, Center for Education and Research on Macromolecules (CERM), Belgium
Lechanteur, Anna ; University of Liège (ULiège), Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, Belgium
Evrard, Brigitte ; University of Liège (ULiège), Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, Belgium
Language :
English
Title :
Impregnation of mesoporous silica with poor aqueous soluble molecule using pressurized carbon dioxide: is the solubility in the supercritical and subcritical phase a critical parameter?
Publication date :
01 July 2020
Journal title :
European Journal of Pharmaceutical Sciences
ISSN :
0928-0987
eISSN :
1879-0720
Publisher :
Elsevier, Amsterdam, Netherlands
Volume :
150
Pages :
105332
Peer reviewed :
Peer Reviewed verified by ORBi
Name of the research project :
SOLPHARE project
Funders :
FEDER - Fonds Européen de Développement Régional [BE]
Ahern, R.J., Hanrahan, J.P., Tobin, J.M., Ryan, K.B., Crean, A.M., Comparison of fenofibrate-mesoporous silica drug-loading processes for enhanced drug delivery. Eur. J. Pharm. Sci. 50 (2013), 400–409.
Belhadj-Ahmed, F., Badens, E., Llewellyn, P., Denoyel, R., Charbit, G., Impregnation of vitamin E acetate on silica mesoporous phases using supercritical carbon dioxide. J. Supercrit. Fluids 51 (2009), 278–286.
Bouledjouidja, A., Masmoudi, Y., Sergent, M., Trivedi, V., Meniai, A., Badens, E., Drug loading of foldable commercial intraocular lenses using supercritical impregnation. Int. J. Pharm. 500 (2016), 85–99.
Butler, J.M., Dressman, J.B., The developability classification system: application of biopharmaceutics concepts to formulation development. J. Pharm. Sci. 99 (2010), 4940–4954.
Cha, K.H., Cho, K.J., Kim, M.S., Kim, J.S., Park, H.J., Park, J., Cho, W., Park, J.S., Hwang, S.J., Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide. Int. J. Nanomed. 7 (2012), 5565–5575.
Charnay, C., Bégu, S., Tourné-Péteilh, C., Nicole, L., Lerner, D.A., Devoiselle, J.M., Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur J Pharm Biopharm. 57 (2004), 533–540.
Chaudhari, S.P., Gupte, A., Mesoporous silica as carrier for amorphous solid dispersion. BJPR 16 (2017), 1–19.
Chen, Y.M., Lin, P.C., Tang, M., Chen, Y.P., Solid solubility of antilipemic agents and micronization of gemfibrozil in supercritical carbon dioxide. J. Supercrit. Fluids. 52 (2010), 175–182.
Dohrn, R., Bertakis, E., Behrend, O., Voutsas, E., Tassios, D., Melting point depression by using supercritical CO2 for a novel melt dispersion micronization process. J. Mol. Liq. 131-132 (2007), 53–59.
Dwyer, L.M., Michaelis, V.K., O'Mahony, M., Griffin, R.G., Myerson, A.S., Confined crystallization of fenofibrate in nanoporous silica. Cryst. Eng. Comm. 17 (2015), 7922–7929.
Edueng, K., Mahlin, D., Bergström, C.A.S., The need for restructuring the disordered science of amorphous drug formulations. Pharm. Res. 34 (2017), 1754–1772.
Gignone, A., Manna, L., Ronchetti, S., Banchero, M., Onida, B., Incorporation of clotrimazole in ordered mesoporous silica by supercritical CO2. Microporous Mesoporous Mater. 200 (2014), 291–296.
Garcia-Casa, I., Montes, A., Valor, D., Pereyra, C., Martinez de la Ossa, E., Impregnation of mesoporous silica with mangiferin using supercritical CO2. J. Supercrit. Fluids 140 (2018), 129–136.
Gurikov, P., Smirnova, I., Amorphization of drugs by adsorptive precipitation from supercritical solutions: a review. J. Supercrit. Fluids 132 (2017), 105–125.
Kinnari, P., Mäkilä, E., Heikkilä, T., Salonen, J., Hirvonen, J., Santos, A., Comparison of mesoporous silicon and non-ordered mesoporous silca materials as drug carriers for itraconazole. Int. J. Pharm. 414 (2011), 148–156.
Li-Hong, W., Xin, C., Hui, X., Li-Li, Z., Jing, H., Mei-Juan, Z., Jie, L., Yi, L., Jin-Wen, L., Wei, Z., Gang, C., A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique. Int. J. Pharm. 454 (2013), 135–142.
Limnell, T., Santos, H.A., Mäkilä, E., Heikkilä, T., Salonen, J., Murzin, D.Y., Kumar, N., Laaksonen, T., Peltonen, L., Hirvonen, J., Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. J. Pharm. Sci. 100 (2011), 3294–3306.
Lindenberg, M., Kopp, S., Dressman, J.B., Classification of orally administered drugs on the World Health Organization list of essential medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm. 58 (2004), 265–278.
Lipinski, C.A., Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 44 (2000), 235–249.
Ljubec, B., Hrnčic, M.K., Cör, D., Kravanja, G., Knez, Z., Phase equilibria of the binary systems of fenofibrate and dense gases (carbon dioxide, propane and trifluoromethane). Fluid Phase Equilib. 474 (2018), 110–115.
Lumay, G., Pillitteri, S., Marck, M., Monsuur, F., Pauly, T., Ribeyre, Q., Francqui, F., Vandewalle, N., Influence of mesoporous silica on powder flow and electrostatic properties on short and long term. J. Drug Deliv. Sci. Tec., 53, 2019.
Ma, X., Feng, H., Liang, C., Liu, X., Zeng, F., Wang, Y., Mesoporous silica as micro/nano-carrier: from passive to active cargo delivery, a mini review. Mater. Sci. 33 (2017), 1067–1074.
Maleki, A., Kettiger, H., Schoubben, A., Rosenholm, J.M., Ambrogi, V., Hamidi, M., Mesoporous silica materials: from physical-chemical properties to enhanced dissolution of poorly water-soluble drugs. J. Control. Release 262 (2017), 329–347.
McCarthy, C.A., Ahern, R.J., Dontireddy, R., Ryan, K.B., Crean, A.M., Mesoporous silica formulation strategies for drug dissolution enhancement: a review. Expert Opin. Drug Deliv. 13 (2016), 93–108.
Morère, J., Tenorio, M.J., Torralvo, M.J., Pando, C., Renuncio, J.A.R., Cabañas, A., Deposition of Pd into mesoporous silica SBA-15 using supercritical carbon dioxide. J. Supercrit. Fluids 56 (2011), 213–222.
Mu, H., Holm, R., Müllertz, A., Lipid-based formulations for oral administration of poorly water-soluble drugs. Int. J. Pharm. 453 (2013), 215–224.
Müllertz, A., Obgonna, A., Ren, S., Rades, T., New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J. Pharm. Pharmacol. 62 (2010), 1622–1636.
Nuchuchua, O., Nejadnik, M.R., Goulooze, S.C., Ljeskovic, N.J., Every, H.A., Jiskoot, W., Characterization of drug delivery particles produced by supercritical carbon dioxide technologies. J. Supercrit. Fluids 128 (2017), 244–262.
Pacheco, P.A., Rodriguez, L.N.C., Ferreira, J.F.S., Gomes, A.C.P., Verissimo, C.J., Louvandini, H., Costa, R.L.D., Katiki, L.M., Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendzole. Parasitol. Res. 117 (2018), 705–712.
Padrela, L., Rodriguez, M.A., Duarte, A., Dias, A.M.A., Braga, M.E.M., De Sousa, H.C., Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals – a comprehensive review. Adv. Drug Deliv. Rev. 131 (2018), 22–78.
Pan, X., Julian, T., Augsburger, L., Increasing the dissolution rate of a low-solubility drug through a crystalline-amorphous transition: a case study with indomethacin. Drug Dev. Ind. Pharm. 34 (2009), 221–231.
Pestieau, A., Krier, F., Lebrun, P., Brouwers, A., Streel, B., Evrard, B., Optimization of a PGSS (particles from gas saturated solutions) process for a fenofibrate lipid-based solid dispersion. Int. J. Pharm. 485 (2015), 295–305.
Sanganwar, G.P., Gupta, R.B., Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide. Int. J. Pharm. 360 (2008), 213–218.
Tahvanainen, M., Rotko, T., Mäkilä, E., Santos, H.A., Neves, D., Laaksonen, T., Kallonen, A., Hämäläinen, K., Peura, M., Serimaa, R., Salonen, J., Hirvonen, J., Peltonen, L., Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles. Int. J. Pharm. 422 (2012), 125–131.
Tong, T.W.Q., Practical Aspects of Solubility Determination in Pharmaceutical Preformulation. Augustijns, P., Brewster, M.E., (eds.) Solvent Systems and their Selection in Pharmaceutics and Biopharmaceutics, 2007, E-Publishing Inc., New York, 142–154.
Van Speybroeck, M., Mellaerts, R., Mols, R., Thi, T.D., Martens, J.A., Van Humbeeck, J., Annaert, P., Van den Mooter, G., Augustijns, P., Enhanced absorption of the poorly soluble drug fenofibrate by tunning its release rate from ordered mesoporous silica. Eur. J. Pharm. Sci. 41 (2010), 623–630.
Won, D.H., Kim, M.S., Lee, S., Park, J.S, Hwang, S.J., Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int. J. Pharm. 301 (2005), 199–208.
Xu, J., Luo, K.Q., Enhancing the solubility and bioavailability of isoflavone by particle size reduction using a supercritical carbon dioxide-based precipitation process. Chem. Eng. Res. Des. 92 (2014), 2542–2549.
Zhang, Z., Quan, G., Wu, Q., Zhou, C., Li, F., Bai, X., Li, G., Pan, X., Wu, C., Loading amorphous Asarone in mesoporous silica SBA-15 through supercritical carbon dioxide technology to enhance dissolution and bioavailability. Eur. J. Pharm. Biopharm. 92 (2015), 28–31 (2015).
